Additional Insights Into Pergolide-Associated Valvular Heart Disease
- 30 June 2003
- journal article
- editorial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 78 (6) , 684-686
- https://doi.org/10.4065/78.6.684
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- The US Food and Drug Administration's Registry of Patients With Pergolide-Associated Valvular Heart DiseaseMayo Clinic Proceedings, 2003
- Drug-Related Valvular Heart Disease: Here We Go Again: Will We Do Better This Time?Mayo Clinic Proceedings, 2002
- Valvular Heart Disease in Patients Taking PergolideMayo Clinic Proceedings, 2002
- Diet Drug-Related Cardiac Valve Disease: The Mayo Clinic Echocardiographic Laboratory ExperienceMayo Clinic Proceedings, 2000
- Echocardiographic Improvement Over Time After Cessation of Use of Fenfluramine and PhentermineMayo Clinic Proceedings, 1999
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Molecular biology of 5-HT receptorsNeuropharmacology, 1994